In this study one cetuximab-sensitive cell line (UT-SCC-14, established from a tongue tumour) with a high EGFR expression and one resistant cell line (UT-SCC-2, established from a floor of mouth tumour) with a low EGFR expression were used. Here, EGFR is linked to neoplasm of floor of mouth.